Ken Herrmann
Ken Herrmann, MD, MBA
Ken Herrmann is Professor of Nuclear Medicine at the Universitätsklinikum Essen, Germany. Herrmann is Section Editor of The Journal of Nuclear Medicine and Imaging Editor of European Urology.
Disclosures: Honoraria and/or fees from AdvanCell, Aktis Oncology, Amgen, AstraZeneca, Bain Capital, Bayer, Boston Scientific, Convergent Therapeutics, Curium Pharma, Debiopharm, EcoR1, Fusion, GE Healthcare, Immedica, Isotopen Technologien München, Janssen, Merck, MSD, Molecular Partners, Novartis (Advanced Accelerator Applications), NVision, Pfizer, Pentixapharm, POINT Biopharma, Radiopharm Theranostics, Rhine Pharma, Siemens Healthineers, SOFIE Biosciences, Telix, Theragnostics, and Y-mAbs Therapeutics.
View content featuring Herrmann:
This content has been developed independently by Medthority who previously received educational funding from Pfizer in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.
of interest
are looking at
saved
next event